- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02496416
Comparison of Two Physical Activity Interventions in Individuals With Multiple Sclerosis
Comparison of Two Physical Activity Interventions in Individuals With Multiple Sclerosis: A Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim 1. Examine the impact of aquatic exercise on cognitive abilities. The proposed study will test the hypotheses that, compared to the wait-list control group, the treatment group will demonstrate significantly greater improvements in cognitive outcomes, specifically: processing speed, executive functioning, working memory and long-term memory.
Aim 2. The current study will examine the impact of an aquatic exercise on fatigue, mood, wellness, QOL and physical functioning. Specifically the investigators predict that aquatic exercise will lead to improvements in: 1.Fatigue 2. Health related QOL 3. Depression/anxiety 4. Self-efficacy 5. Physical Functioning (i.e. gait and walking).
Aim 3: Examine the long-term effects of aquatic exercise on all outcome measures.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Angela Smith, MA
- Phone Number: 973-324-8448
- Email: asmith@kesslerfoundation.org
Study Locations
-
-
New Jersey
-
East Hanover, New Jersey, United States, 07936
- Recruiting
- Kessler Foundation
-
Contact:
- Nancy B Moore, MA
- Phone Number: 973-324-8450
- Email: nbmoore@kesslerfoundation.org
-
Contact:
- Angela A Smith, MA
- Phone Number: 973-324-8448
- Email: asmith@kesslerfoundation.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of MS.
- between the ages of 18-65.
- read and speak English fluently.
Exclusion Criteria:
- history of significant substance abuse.
- history of neurological disease other than MS (for example, stroke, epilepsy, or brain injury).
- history of significant psychiatric illness (for example, bipolar disorder or schizophrenia).
- has engaged in more than 30 minutes of moderate to strenuous exercise per week during the past six months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment
The treatment group will participate in an eight week aquatic exercise program during weeks 2-9 of the study.
The aquatic exercise program will consist of 45 minute classes held 3 days/week for 8 weeks (18 hours total).
The program is based on guidelines provided by the National Multiple Sclerosis Society (NMSS) and will be led by an aquatic fitness instructor certified to teach individuals with MS at the YMCA in Randolph, NJ..
The exercises will focus on improving flexibility, balance and strength.
Equipment such as water mitts, paddles, noodles and bands will be used to increase the level of difficulty as needed.
|
The aquatic exercise program will consist of 45 minute classes held 3 days/week for 8 weeks (18 hours total).
The program is based on guidelines provided by the National Multiple Sclerosis Society (NMSS) and will be led by an aquatic fitness instructor certified to teach individuals with MS at the YMCA in Scotch Plains-Fanwood.
The exercises will focus on improving flexibility, balance and strength.
Equipment such as water mitts, paddles, noodles and bands will be used to increase the level of difficulty as needed.
|
|
Active Comparator: Control
The control group will participate in an eight week stretching program during weeks 2-9 of the study.
The stretching program will consist of 45 minute classes held 3 days/week for 8 weeks (18 hours total).
The program is based on guidelines provided by the National Multiple Sclerosis Society (NMSS) and will be conducted online via a secure video-conferencing website.
|
The stretching program will consist of 45 minute classes held 3 days/week for 8 weeks (18 hours total).
The program is based on guidelines provided by the National Multiple Sclerosis Society (NMSS) and will be conducted online via a secure video-conferencing website.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognition measured by results of standardized neuropsychological tests
Time Frame: 8 weeks
|
standardized measures of processing speed, executive functioning, working memory and long-term memory
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fatigue measured by self-report questionnaires
Time Frame: 8 weeks
|
Modified Fatigue Impact Scale (MFIS) and Fatigue Severity Scale (FSS_
|
8 weeks
|
|
Quality of Life measured by self report questionnaires
Time Frame: 8 weeks
|
General QOL measured with Satisfaction with Life Scale (SWLS) and HRQOL measured with Health Status Questionnaire (HSQ).
|
8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Helen Genova, PhD, Kessler Foundation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-876-15
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Aquatic Exercise Program
-
José M. CancelaCompletedPregnancy | Balance | Aquatic Physical ExerciseSpain
-
Instituto Politécnico de LeiriaInstituto Politécnico de Castelo BrancoCompletedChronic Low-back Pain (cLBP)Portugal
-
Technical University of LisbonCompleted
-
Gaziosmanpasa Research and Education HospitalRecruitingSarcopenia | Sarcopenia in ElderlyTurkey (Türkiye)
-
Federal University of PelotasRecruiting
-
Princess Nourah Bint Abdulrahman UniversityAksaray UniversityCompletedAutism Spectrum DisorderTurkey (Türkiye)
-
University of EdinburghCompletedChronic Low Back Pain (Non-specific, Uncomplicated)United Kingdom
-
Alaa Noureldeen KoraActive, not recruitingCerebral Palsy (CP) | Hemiplegia and HemiparesisEgypt
-
Pusan National UniversityMarymount University; Dong-Eui UniversityCompletedPeripheral Arterial Disease | Peripheral Artery Disease | Vascular Function | Exercise Tolerance
-
Alanya Alaaddin Keykubat UniversityPamukkale UniversityCompletedFall | Geriatrics | Physical Functional Performance | Exercise TherapyTurkey